PNC Financial Services Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

PNC Financial Services Group’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-917	Closed	-$3.71K	–	4860
2023 Q4	$3.71K	Buy	+917	New	+$2.8K	﹤0.01%	4027

PNC Financial Services Group's THRX Position: Q1 2024 in Review

PNC Financial Services Group sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 917 shares — an estimated $3.71K sold.

PNC Financial Services Group first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $3.71K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

PNC Financial Services Group reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
PNC Financial Services Group sold 917 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $3.71K.
PNC Financial Services Group first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
PNC Financial Services Group's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $3.71K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.